https://investorshub.advfn.com/boards/read_msg.asp
Post# of 60
(Total Views: 851)
Posted On: 01/02/2018 2:04:09 PM
https://investorshub.advfn.com/boards/read_ms...=137340414
Great words, very describing of the advantage this product has. Dr Sanderson is a international well-known scientist - this is a heavy confirmation on his work and Lifestyles strong pharma team.
My guess is; within a very close future we will get the results from the clinical studies in Canada. That can be a major catalyst, beacause then big pharma will be intrested to get involved one way or another in LDS.
Probably LDS will seek out more global markets, since the patent (-s) are expanding, licensing/royalty deal is possible for 1-2 players in Europe - maybe Germany and Italy since they are already open to medical cannabis.
Great words, very describing of the advantage this product has. Dr Sanderson is a international well-known scientist - this is a heavy confirmation on his work and Lifestyles strong pharma team.
My guess is; within a very close future we will get the results from the clinical studies in Canada. That can be a major catalyst, beacause then big pharma will be intrested to get involved one way or another in LDS.
Probably LDS will seek out more global markets, since the patent (-s) are expanding, licensing/royalty deal is possible for 1-2 players in Europe - maybe Germany and Italy since they are already open to medical cannabis.
(0)
(0)Core One Labs Inc. (CLABF) Stock Research Links
Robert
Scroll down for more posts ▼